Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
1.1 To collect pathological tumor specimens of patients with metastatic colorectal cancer in
a prospective fashion for correlative studies of response to an oxaliplatin based
chemotherapy regimen.
1.2 To determine a gene expression profile that predicts response to an oxaliplatin based
chemotherapy regimen in this cohort of patients.